IDH2 and glioblastoma: The rare occurrence of IDH-mutation, a genetic marker of secondary GBM that is mostly absent in primary GBM and its correlation with better prognosis could indicate that this mutation is a hindrance in the progression from low grade glioma (LGG) to GBM since it changes the epigenetic state of multiple genes involved in important cellular processes.